Key points
- A deadly consequence of the opioid crisis is increased blood-borne infections, including viral hepatitis, HIV, and bacterial and fungal infections.
- Infections are spread through the sharing of contaminated syringes and drug preparation equipment as well as through low vaccination rates among populations at risk for infection.

What CDC is doing

CDC's infectious disease programs work to implement evidence-based prevention programs community settings, and to stop the spread of infectious diseases like hepatitis C, hepatitis B, and HIV among people who inject drugs. Access to comprehensive prevention services is essential for all persons who inject drugs.
Syringe services programs (SSPs) are community-based prevention programs that can provide a range of services, including access to and disposal of sterile syringes and injection equipment, vaccination, testing, and linkage to infectious disease care and substance use treatment. Nearly 30 years of research shows that comprehensive syringe services programs (SSPs) are safe, effective, and cost-saving, do not increase illegal drug use or crime, and play an important role in reducing the transmission of viral hepatitis, HIV and other infections. Below are a summary of CDC resources on infectious disease and injection drug use.
Assistance for persons who use drugs
SAMHSA's referral helpline
Call SAMHSA's Referral Helpline 24/7 at 1-800-662-HELP (1-800-662-4357) or visit SAMHSA Find Help & Treatment to find services near you for:
- Substance Abuse and/or Mental Health Treatment Facility Locator
- Buprenorphine Physicians & Treatment Program
- Opioid Treatment